- Home
- AUPH vs UVV Comparison
AUPH vs UVV Comparison
Compare AUPH & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- UVV
- Stock Information
- Founded
- AUPH 1993
- UVV 1886
- Country
- AUPH Canada
- UVV United States
- Employees
- AUPH N/A
- UVV N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- UVV Farming/Seeds/Milling
- Sector
- AUPH Health Care
- UVV Industrials
- Exchange
- AUPH Nasdaq
- UVV Nasdaq
- Market Cap
- AUPH 1.6B
- UVV 1.3B
- IPO Year
- AUPH 1999
- UVV N/A
- Fundamental
- Price
- AUPH $12.54
- UVV $50.98
- Analyst Decision
- AUPH Strong Buy
- UVV
- Analyst Count
- AUPH 2
- UVV 0
- Target Price
- AUPH $13.00
- UVV N/A
- AVG Volume (30 Days)
- AUPH 1.2M
- UVV 167.9K
- Earning Date
- AUPH 11-10-2025
- UVV 08-06-2025
- Dividend Yield
- AUPH N/A
- UVV 6.37%
- EPS Growth
- AUPH N/A
- UVV N/A
- EPS
- AUPH 0.42
- UVV 4.11
- Revenue
- AUPH $260,111,000.00
- UVV $2,943,996,000.00
- Revenue This Year
- AUPH $17.33
- UVV $1.52
- Revenue Next Year
- AUPH $14.31
- UVV $0.97
- P/E Ratio
- AUPH $30.05
- UVV $12.54
- Revenue Growth
- AUPH 25.59
- UVV 4.11
- 52 Week Low
- AUPH $6.55
- UVV $49.40
- 52 Week High
- AUPH $13.54
- UVV $67.33
- Technical
- Relative Strength Index (RSI)
- AUPH 60.86
- UVV 32.16
- Support Level
- AUPH $11.48
- UVV $52.26
- Resistance Level
- AUPH $12.70
- UVV $53.80
- Average True Range (ATR)
- AUPH 0.34
- UVV 0.78
- MACD
- AUPH 0.13
- UVV -0.18
- Stochastic Oscillator
- AUPH 89.64
- UVV 0.00
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About UVV Universal Corporation
Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.